EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MEIS2 suppresses breast cancer development by downregulating IL10

Yongzhi Xiao, Yingzhe Liu, Yangqing Sun, Changhao Huang, Shangwei Zhong iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.2064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Yongzhi Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Diagnosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Homeodomain Proteins, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Health Research Project of Hunan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) is the most commonly diagnosed female cancer. Homeobox protein MEIS2, a key transcription factor, is involved in the regulation of many developmental and cellular processes. However, the role of MEIS2 in the development of breast cancer is still unclear.

Aims

We aimed to examine the role of myeloid ecotropic insertion site (MEIS2) in breast cancer and the association of MEIS2 with breast cancer clinical stages and pathological grades. We revealed the underlying mechanism by which MEIS2 affected breast cancer cell growth and tumor development. Methods and Results Using human BC cell lines, clinical samples and animal xenograft model, we reveal that MEIS2 functions as a tumor suppressor in breast cancer. The expression of MEIS2 is inversely correlated with BC clinical stages and pathological grades. MEIS2 knockdown (MEIS2‐KD) promotes while MEIS2 overexpression suppresses breast cancer cell proliferation and tumor development in vitro and in animal xenograft models, respectively. To determine the biological function of MEIS2, we screen the expression of a group of MEIS2 potential targeting genes in stable‐established cell lines. Results show that the knockdown of MEIS2 in breast cancer cells up‐regulates the IL10 expression, but MEIS2 overexpression opposed the effect on IL10 expression. Furthermore, the suppressive role of MEIS2 in breast cancer cell proliferation is associated with the IL10 expression and myeloid cells infiltration.

Conclusion

Our study demonstrates that the tumor suppressor of MEIS2 in breast cancer progression is partially via down regulating the expression of IL10 and promoting myeloid cells infiltration. Targeting MEIS2 would be a potentially therapeutic avenue for BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHomeodomain ProteinsCell ProliferationGene Expression Regulation, NeoplasticTranscription FactorsInterleukin-10HumansFemaleAnimalsMiceCell Line, TumorDown-RegulationXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

IL10MEIS2breast cancermyeloid cells

Substanzen

Homeodomain ProteinsMEIS2 protein, humanTranscription FactorsInterleukin-10IL10 protein, human

Autor:innen und Institutionen

  • Department of Ultrasound Diagnosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Xiangya International Medical Center, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Oncology, Xiangya Hospital, Central South University, Hunan, China.
  • The Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, China.

ORCID-Profile: Shangwei Zhong

Förderung

  • The Health Research Project of Hunan Provincial Health Commission

Zitieren

APA

Xiao, Y., Liu, Y., Sun, Y., Huang, C., & Zhong, S. (2024). MEIS2 suppresses breast cancer development by downregulating IL10. Cancer Reports. https://doi.org/10.1002/cnr2.2064

Vancouver

Xiao Y, Liu Y, Sun Y, Huang C, Zhong S. MEIS2 suppresses breast cancer development by downregulating IL10. Cancer Reports. 2024. doi:10.1002/cnr2.2064

BibTeX
@article{Xiao2024,
  author = {Xiao, Yongzhi and Liu, Yingzhe and Sun, Yangqing and Huang, Changhao and Zhong, Shangwei},
  title = {MEIS2 suppresses breast cancer development by downregulating IL10},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.2064}
}
Kostenlos starten →